Janux Therapeutics Inc (JANX) — Capital Reinvestment Ratio

Latest as of March 2021: 0.03x

Janux Therapeutics Inc (JANX) has a Capital Reinvestment Ratio of 0.03x as of March 2021, meaning it reinvests 0% of its operating cash flow ($5.56 Million) in capital expenditures ($153.00K). See Janux Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$5.56 Million

USD

Capital Expenditures

$153.00K

USD

Data as of

Mar 2021

Most recent filing

Annual Capital Reinvestment Ratio for Janux Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Janux Therapeutics Inc from None to None. For live market cap and broader valuation context, see Janux Therapeutics Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow